CN Patent

CN106278907B — 一种盐酸曲恩汀化合物

Assigned to Kemus medical technology (Shanghai) Co.,Ltd. · Expires 2019-06-21 · 7y expired

What this patent protects

本发明公开了一种盐酸曲恩汀化合物，其特征在于该化合物是以晶型的形式存在，文中还公布了该化合物的制备方法和用途，以及包含该化合物的药物组合物。本发明盐酸曲恩汀的晶型特征为：稳定性好、吸湿性低、纯度高、杂质含量低。

USPTO Abstract

本发明公开了一种盐酸曲恩汀化合物，其特征在于该化合物是以晶型的形式存在，文中还公布了该化合物的制备方法和用途，以及包含该化合物的药物组合物。本发明盐酸曲恩汀的晶型特征为：稳定性好、吸湿性低、纯度高、杂质含量低。

Drugs covered by this patent

Patent Metadata

Patent number
CN106278907B
Jurisdiction
CN
Classification
—
Expires
2019-06-21
Drug substance claim
No
Drug product claim
No
Assignee
Kemus medical technology (Shanghai) Co.,Ltd.
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.